How has the safety looked (no pun intended)? Wasn't there a European trial a few years back that set back gene therapy because of leukemia in some patients?
It sure seems like a lot of people are working on wet AMD, does anyone know any promising dry AMD candidates (outside of treatments to stop progression to wet)?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.